Surmodics, Inc. Stock

Equities

SRDX

US8688731004

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-04-19 pm EDT 5-day change 1st Jan Change
26.49 USD +0.38% Intraday chart for Surmodics, Inc. -1.89% -27.13%
Sales 2024 * 120M Sales 2025 * 136M Capitalization 377M
Net income 2024 * -16M Net income 2025 * 5M EV / Sales 2024 * 3.15 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 2.77 x
P/E ratio 2024 *
-22.6 x
P/E ratio 2025 *
66.2 x
Employees 376
Yield 2024 *
-
Yield 2025 *
-
Free-Float 96.25%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.38%
1 week-1.89%
Current month-9.71%
1 month-4.68%
3 months-22.02%
6 months-9.96%
Current year-27.13%
More quotes
1 week
26.22
Extreme 26.22
27.28
1 month
26.22
Extreme 26.22
29.78
Current year
26.22
Extreme 26.22
37.50
1 year
16.79
Extreme 16.79
39.41
3 years
16.00
Extreme 16
62.27
5 years
16.00
Extreme 16
62.27
10 years
16.00
Extreme 16
82.35
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 10-12-26
Director of Finance/CFO 57 07-01-31
Corporate Officer/Principal 55 18-10-31
Members of the board TitleAgeSince
Director/Board Member 77 14-02-16
Chairman 70 08-01-28
Director/Board Member 68 01-12-31
More insiders
Date Price Change Volume
24-04-19 26.49 +0.38% 54,909
24-04-18 26.39 -0.49% 140,406
24-04-17 26.52 -0.30% 443,034
24-04-16 26.6 +0.68% 155,354
24-04-15 26.42 -2.15% 232,337

Delayed Quote Nasdaq, April 19, 2024 at 04:00 pm EDT

More quotes
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The Company's segments include Medical Device and IVD. The Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral, coronary and structural heart. It manufactures vascular intervention medical devices, including drug-coated balloons, and radial access balloon catheters and guide sheaths. The IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
26.49 USD
Average target price
59 USD
Spread / Average Target
+122.73%
Consensus